Literature DB >> 25500267

Mechanism-based inactivation of cytochrome P450 2B6 by isoimperatorin.

Jiaojiao Cao1, Liwei Zheng1, Lin Ji1, Dan Lu1, Ying Peng2, Jiang Zheng3.   

Abstract

Isoimperatorin (IIMP), a 6,7-furanocoumarin derivative, occurs in many common medicinal herbs. Human exposure to IIMP mainly results from intake of fruits, foods and medicinal herbs. We examined the irreversible inhibitory effect of IIMP on cytochrome P450 2B6. IIMP was found to cause time-dependent inhibition of CYP2B6. In addition, the loss of CYP2B6 activity occurred in a NAPDH- and concentration-dependent manner. About 60% of activity of CYP2B6 was suppressed after its incubation with IIMP at 25 μM for 9 min. Enzyme kinetic studies were performed, kinact for IIMP was found to be 0.071 min(-1), and KI was 17.1 μM, respectively. Glutathione and catalase/superoxide dismutase showed little protective effects on CYP2B6 against the inactivation by IIMP. S-Mephenytoin, a substrate of CYP2B6, mildly prevented the enzyme from the inactivation induced by IIMP. The estimated partition ratio of the inactivation was approximately 211. Additionally, a γ-ketoenal intermediate was identified in microsomal incubations with IIMP. CYPs 2B6, 2D6, and 1A2 were the major enzymes responsible for the metabolic activation of IIMP. In conclusion, IIMP is a mechanism-based inactivator of CYP2B6. The formation of γ-ketoenal intermediate may be responsible for the enzyme inactivation.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cytochrome P450 2B6; Isoimperatorin; Mechanism-based inactivator; Reactive metabolite

Mesh:

Substances:

Year:  2014        PMID: 25500267     DOI: 10.1016/j.cbi.2014.12.009

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  4 in total

1.  A Molecular Aspect in the Regulation of Drug Metabolism: Does PXR-Induced Enzyme Expression Always Lead to Functional Changes in Drug Metabolism?

Authors:  Yuan Wei; Chenxiao Tang; Vinayak Sant; Song Li; Samuel M Poloyac; Wen Xie
Journal:  Curr Pharmacol Rep       Date:  2016-05-04

2.  Inhibition of cytochrome P450 2B6 by Astragalus extract mixture HT042.

Authors:  Harim Kim; Yejin Lee; Vitchan Kim; Rowoon Lee; Soo Kyung Bae; Mi-Kyoung Kwak; Sung Hoon Lee; Donghak Kim
Journal:  Toxicol Res       Date:  2019-12-04

3.  Exploring the Scientific Rationality of the Phenomenon of "Different Dosage Forms of the Same Prescription" of Chinese Proprietary Medicine Based on Biopharmaceutical Properties of Powder and Pill of Chuanxiong Chatiao Prescription.

Authors:  Zhong-Huan Qu; Lin Liu; Xiao-Fei Zhang; Dong-Yan Guo; Bing-Tao Zhai; Jun-Bo Zou; Ya-Jun Shi
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

Review 4.  Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases.

Authors:  Gregory Ondieki; Makafui Nyagblordzro; Siambi Kikete; Rongjia Liang; Lili Wang; Xin He
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-31       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.